stock offering
Proteomics Goes Public in 2021
Premium
Seven proteomics firms, ranging from tools companies to diagnostics outfits, listed on public markets in 2021 in a sign of growing interest in the space.
OpGen Enters $15M Registered Direct Offering Agreement
The agreement with a single investor is for an aggregate 150,000 shares of convertible preferred stock and warrants to purchase up to 7.5 million shares of common stock.
Natera Prices, Upsizes Public Stock Offering
The company said it plans to use the proceeds for working capital and general corporate purposes, and continued investments in R&D for its core technology.
Sera Prognostics Goes Public With $75M IPO
The firm is offering 4,687,500 shares of its common stock at $16 per share. Its first commercial product is the PreTRM test for predicting the risk of a preterm birth.
Angle to Raise £20M Through Stock Placement
The company said the proceeds of the offering will be used in part to continue development of its flagship Parsortix tumor cell-sorting system in prostate cancer.